Journal of General Internal Medicine

, Volume 16, Issue 6, pp 376–383

Antibiotic use in ontario facilities that provide chronic care

  • Mark Loeb
  • Andrew E. Simor
  • Lisa Landry
  • Stephen Walter
  • Margaret McArthur
  • JoAnn Duffy
  • Debora Kwan
  • Allison McGeer
Original Articles

Abstract

OBJECTIVE: To determine the incidence and variability of antibiotic use in facilities which provide chronic care and to determine how often clinical criteria for infection are met when antibiotics are prescribed in these facilities.

DESIGN: A prospective, 12-month, observational cohort study.

SETTING: Twenty-two facilities which provide chronic care in southwestern Ontario.

PARTICIPANTS: Patients who were treated with systemic antibiotics over the study period.

MEASUREMENTS: Characteristics of antibiotic prescriptions (name, dose, duration, and indication) and clinical features of randomly selected patients who were treated with antibiotics.

RESULTS: A total of 9,373 courses of antibiotics were prescribed for 2,408 patients (66% of the patients in study facilities). The incidence of antibiotic prescriptions in the facilities ranged from 2.9 to 13.9 antibiotic courses per 1,000 patient-days. Thirty-six percent of antibiotics were prescribed for respiratory tract infections, 33% for urinary infections, and 13% for skin and soft tissue infections. Standardized surveillance definitions of infection were met in 49% of the 1,602 randomly selected patients who were prescribed antibiotics. Diagnostic criteria for respiratory, urinary, and skin infection were met in 58%, 28%, and 65% of prescriptions, respectively. One third of antibiotic prescriptions for a urinary indication were for asymptomatic bacteriuria. Adverse reactions were noted in 6% of prescriptions for respiratory and urinary infections and 4% of prescriptions for skin infection.

CONCLUSIONS: Antibiotic use is frequent and highly variable amongst patients who receive chronic care. Reducing antibiotic prescriptions for asymptomatic bacteriuria represents an important way to optimize antibiotic use in this population.

Key words

antibiotic use chronic care facilities infection 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mylotte JM. Measuring antibiotic use in a long-term care facility. Am J Infect Control. 1996;24:174–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Montgomery P, Semenchuk M, Nicolle LE. Antimicrobial use in nursing homes in Manitoba. J Geriatr Drug Ther. 1995;9:55–74.CrossRefGoogle Scholar
  3. 3.
    Warren JW, Palumbo FB, Fitterman L, Speedie SM. Incidence and characteristics of antibiotic use in aged nursing home patients. J Am Geriatr Soc. 1991;39:963–72.PubMedGoogle Scholar
  4. 4.
    Katz PR, Beam TR, Brand F, Boyce K. Antibiotic use in the nursing home. Physician practice patterns. Arch Intern Med. 1990;150:1465–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Smith PW. Nursing home infection control: a status report. Infect Control Hosp Epidemiol. 1998;19:366–9.PubMedGoogle Scholar
  6. 6.
    Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA. 1996;275:234–40.PubMedCrossRefGoogle Scholar
  7. 7.
    Armstrong-Evans M, Litt M, McArthur MA, et al. Control of transmission of vancomycin-resistant Enterococcus faecium in a long-term-care facility. Infect Control Hosp Epidemiol. 1999;20:312–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Greenaway CA, Miller MA. Lack of transmission of vancomycin-resistant enterococci in three long-term-care facilities. Infect Control Hosp Epidemiol. 1999;20:341–3.PubMedCrossRefGoogle Scholar
  9. 9.
    Wiener J, Quinn JP, Bradford PA, et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA. 1999;281:517–23.PubMedCrossRefGoogle Scholar
  10. 10.
    Terpenning MS, Bradley SF, Yan JY, Chenoweth CE, Jorgensen KA, Kauffman CA. Colonization and infection with antibiotic-resistant bacteria in a long-term care facility. J Am Geriatr Soc. 1994;42:1062–9.PubMedGoogle Scholar
  11. 11.
    Wingard E, Shlaes JH, Mortimer EA, Shlaes DM. Colonization and cross-colonization of nursing home patients with trimethoprim-resistant gram-negative bacilli. Clin Infect Dis. 1993;16:75–81.PubMedGoogle Scholar
  12. 12.
    Chenoweth CE, Bradley SF, Terpenning MS, et al. Colonization and transmission of high-level gentamicin-resistant enterococci in a long-term care facility. Infect Control Hosp Epidemiol. 1994;15:703–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Gaynes RP, Weinstein RA, Chamberlin W, Kabins SA. Antibiotic-resistant flora in nursing home patients admitted to the hospital. Arch Intern Med. 1985;145:1804–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Rice LB, Willey SH, Papanicolaou GA, et al. Outbreak of ceftazidime resistance caused by extended-spectrum B-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother. 1990;34:2193–9.PubMedGoogle Scholar
  15. 15.
    Muder RR, Brennen C, Goetz AM, Wagener MM, Rihs JD. Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center. Antimicrob Agents Chemother. 1991;35:256–8.PubMedGoogle Scholar
  16. 16.
    Nicolle LE, Bentley D, Garibaldi R, Neuhaus E, Smith P. Antimicrobial use in long-term care facilities. Infect Control Hosp Epidemiol. 1996;17:119–28.PubMedCrossRefGoogle Scholar
  17. 17.
    Nicolle LE, Strausbaugh LJ, Garibaldi RA. Infections and antibiotic resistance in nursing homes. Clin Microbiol Rev. 1996;9:1–17.PubMedGoogle Scholar
  18. 18.
    Strausbaugh LJ, Joseph C. In: Mayhall CG, ed. Hospital Epidemiology and Infection Control. Baltimore, Md: Williams and Wilkins; 1996:1151–70.Google Scholar
  19. 19.
    Zimmer JG, Bentley DW, Valenti WM, Watson NM. Systemic antibiotic use in nursing homes. A quality assessment. J Am Geriatr Soc. 1986;34:703–10.PubMedGoogle Scholar
  20. 20.
    Jones SR, Parker DF, Liebow ES, Kimbrough RC, Frear RS. Appropriateness of antibiotic therapy in long-term care facilities. Am J Med. 1987;83:499–502.PubMedCrossRefGoogle Scholar
  21. 21.
    McGeer A, Campbell B, Emori TG, et al. Definitions of infection for surveillance in long-term care facilities. Am J Infect Control. 1991;19:1–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Chambers LW, Labelle R, Gafni A, Goeree R. The Organization and Financing of Public and Private Sector Long Term Care Facilities for the Elderly in Canada, Chapter 6: Ontario Report. McMaster University Centre for Health Economics and Policy Analysis Working Paper 92-8; 1992.Google Scholar
  23. 23.
    Nicolle LE. Asymptomatic bacteriuria in the elderly. Infect Dis Clin North Am. 1997;11:647–62.PubMedCrossRefGoogle Scholar
  24. 24.
    Nicolle LE, Bjornson J, Harding GK, MacDonnel JA. Bacteriuria in elderly institutionalized men. N Engl J Med. 1983;309:1420–5.PubMedCrossRefGoogle Scholar
  25. 25.
    Nicolle LE, Mayhew JW, Bryan L. Prospective randomized comparison of therapy and no therapy for asymptomatic bacteriuria in institutionalized elderly women. Am J Med. 1987;83:27–33.PubMedCrossRefGoogle Scholar
  26. 26.
    Ouslander JG, Schapira JF, Schnelle JF, et al. Dose eradicating bacteriuria affect the severity of chronic urinary incontinence in nursing home residents? Ann Intern Med. 1995;122:749–54.PubMedGoogle Scholar
  27. 27.
    Abrutyn E, Mossey J, Berlin JA, et al. Does asymptomatic bacteriuria predict mortality and does antimicrobial treatment reduce mortality in elderly ambulatory women. Ann Intern Med. 1994;120:827–33.PubMedGoogle Scholar
  28. 28.
    Garner JS, Bennett JV, Schechler WE, et al. Surveillance of nosocomial infections. In: Brachman PS, Eichhoff TC, eds. Proceedings of the International Conference on Nosocomial Infections. Chicago: American Hospital Association; 1971.Google Scholar
  29. 29.
    Muder RR. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention. Am J Med. 1998;105:319–30.PubMedCrossRefGoogle Scholar
  30. 30.
    Scully BE. Therapy of respiratory tract infections with quinolone antimicrobial agents. In: Hooper DC, Wolfson JS, eds. Quinolone Antimicrobial Therapy. 2nd ed. Washington, DC: American Society for Microbiology; 1993.Google Scholar
  31. 31.
    Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N Engl J Med. 1999;341:233–9.PubMedCrossRefGoogle Scholar

Copyright information

© Blackwell Science Inc 2001

Authors and Affiliations

  • Mark Loeb
    • 1
    • 2
  • Andrew E. Simor
    • 4
  • Lisa Landry
    • 3
    • 4
  • Stephen Walter
    • 2
  • Margaret McArthur
    • 3
    • 4
  • JoAnn Duffy
    • 5
  • Debora Kwan
    • 5
  • Allison McGeer
    • 3
    • 4
  1. 1.Received from the Division of Microbiology, Departments of PathologyMcMaster UniversityHamiltonCanada
  2. 2.Clinical Epidemiology and BiostatisticsMcMaster UniversityHamiltonCanada
  3. 3.Department of Microbiology and Infection ControlMount Sinai and Princess Margaret HospitalsCanada
  4. 4.Department of Microbiology, Sunnybrook and Women’s College Health Sciences CentreUniversity of TorontoTorontoCanada
  5. 5.Departments of Infection Control and PharmacyQueen Elizabeth HospitalTorontoCanada
  6. 6.Hamilton Health Sciences CorporationHamiltonCanada

Personalised recommendations